International Flavors & Fragrances IFF Health & Biosciences — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by International Flavors & Fragrances in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The official record: International Flavors & Fragrances’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about International Flavors & Fragrances's health & biosciences — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is International Flavors & Fragrances's health & biosciences — capex?
- International Flavors & Fragrances (IFF) reported health & biosciences — capex of $55M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — capex changed year-over-year?
- International Flavors & Fragrances's health & biosciences — capex increased by 37.5% year-over-year, from $40M to $55M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — capex?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's health & biosciences — capex has grown at a 1.1% compound annual growth rate (CAGR), from $139M to $145M.
- What does health & biosciences — capex mean?
- Funds used by the Health & Biosciences segment to acquire, upgrade, and maintain physical assets such as property, plants, and equipment. This reflects the segment's commitment to capacity expansion and technological maintenance.